Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole

NCT05635357 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT05635357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05635357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Completed
Start date
November 1, 2022
Completion date
December 31, 2023
Enrollment
16,989 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer